Coyle Financial Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$519K Sell
2,122
-372
-15% -$86.6K 0.11% 63
2025
Q4
$516K Buy
2,494
+1,082
+77% +$214K 0.11% 65
2025
Q3
$262K Sell
1,412
-29
-2% -$4.97K 0.06% 87
2025
Q2
$220K Buy
+1,441
New +$221K 0.06% 85
2022
Q3
Sell
-1,130
Closed -$201K 59
2022
Q2
$201K Sell
1,130
-62
-5% -$11K 0.11% 61
2022
Q1
$211K Hold
1,192
0.11% 68
2021
Q4
$204K Buy
+1,192
New +$195K 0.12% 67
2021
Q2
Sell
-1,250
Closed -$205K 59
2021
Q1
$205K Buy
+1,250
New +$202K 0.14% 58
2018
Q3
Sell
-669
Closed -$81K 173
2018
Q2
$81K Buy
669
+420
+169% +$52.4K 0.08% 60
2018
Q1
$32K Buy
+249
New +$33.7K 0.03% 57

Other funds holding JNJ

Coyle Financial Counsel's JNJ Position: Q1 2026 in Review

Coyle Financial Counsel reduced its Johnson & Johnson (JNJ) stake by 15% in Q1 2026, selling an estimated $86.6K and leaving 2,122 shares worth $519K. The position accounts for 0.11% of the portfolio, ranked #63.

Coyle Financial Counsel first reported a position in JNJ in Q1 2018 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Coyle Financial Counsel held 2,122 shares of Johnson & Johnson worth $519K as of Q1 2026.
  • Coyle Financial Counsel sold 372 Johnson & Johnson shares in Q1 2026, an estimated $86.6K.
  • Johnson & Johnson made up 0.11% of Coyle Financial Counsel's portfolio in Q1 2026, its #63 holding.
  • Coyle Financial Counsel first reported a position in Johnson & Johnson in Q1 2018 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Coyle Financial Counsel's 13F filing for Q1 2026, filed 12 May 2026.